This inventor holds 1 USPTO granted patent. Top assignee: Kollmorgen Corporation. Active years: 1989.
Company Filing History:
Years Active: 1989
Title: Innovations of Robin M Hochstrasser in Biological Treatment Processes.
Introduction
Robin M Hochstrasser is an accomplished inventor based in Philadelphia, PA. He has made significant contributions to the field of biological treatment processes, particularly through his innovative patent. His work focuses on the selective photolysis of biological media, which has important implications for medical treatments.
Latest Patents
Hochstrasser holds a patent for a "Pulsed light selective photolysis process for treatment of biological." This novel irradiation process is designed to treat biological media such as blood fractions, genetically engineered protein products, and vaccine preparations. The process photolyzes nucleic acids preferentially over proteins, effectively inactivating DNA- or RNA-containing pathogens while preserving the functionality of proteins. The method involves irradiating the medium with pulsed light at specific wavelengths and fluxes, allowing nucleic acids to absorb radiation and undergo photolysis, while proteins remain largely intact.
Career Highlights
Hochstrasser is associated with Kollmorgen Corporation, where he applies his expertise in developing innovative solutions for biological treatments. His work has garnered attention for its potential to enhance the safety and efficacy of various medical products.
Collaborations
Hochstrasser has collaborated with notable colleagues such as Paul A Cornelius and Neville Robert Kallenbach. These partnerships have contributed to the advancement of his research and the successful implementation of his patented processes.
Conclusion
Robin M Hochstrasser's innovative work in the field of biological treatment processes exemplifies the impact of targeted inventions on medical science. His contributions continue to pave the way for safer and more effective treatment options.